Skip to main content
logo
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.6067
+0.0322 (5.60%)
At close: Mar 31, 2026, 4:00 PM EDT
0.6199
+0.0132 (2.18%)
After-hours: Mar 31, 2026, 7:58 PM EDT

Humacyte Revenue

In the year 2025, Humacyte had annual revenue of $2.04M. Humacyte had revenue of $467.00K in the quarter ending December 31, 2025.

Revenue (ttm)
$2.04M
Revenue Growth
n/a
P/S Ratio
66.09
Revenue / Employee
$11,076
Employees
184
Market Cap
134.70M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.04M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20221.57M302.00K23.91%
Dec 31, 20211.26M-228.00K-15.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Karyopharm Therapeutics146.07M
Agenus114.20M
Spero Therapeutics66.80M
Precision BioSciences34.26M
Fate Therapeutics6.65M
Equillium4.39M
Oramed Pharmaceuticals2.00M
NeOnc Technologies Holdings59.99K
Revenue Rankings

HUMA News

More News